Angela Zubel, chief development officer, Debiopharm, discusses why 2026 marks a shift from AI pilots to broader operational ...
The Digital Medicine Society (DiMe), through its Digital Health Measurement Collaborative Community (DATAcc), has launched a new educational resource designed to help sponsors and technology ...
This is the Applied Clinical Trials Brief —your fast track to the latest insights shaping clinical operations and drug development.
Miriam Dervan, founder & CEO of mdgroup, discusses how patient-centered strategies rooted in empathy and advocacy engagement ...
Mike Wenger, chief innovation officer at CRIO, explains how AI can responsibly support data quality and monitoring with ...
Using KRIs or SDM, sponsors can detect a variety of emerging risks, including inadequate adverse-event reporting, protocol ...
Holly Leslie, vice president of services at Ledger Run, discusses how persistent payment friction, increasing administrative ...
In today’s ACT Brief, we cover a new real-world data collaboration aimed at scalable interoperability, how AI fits into ...
Jeremy Wyatt, CEO, Ametris, explains how digital endpoints improve trial sensitivity, patient centricity, and efficiency through continuous real-world data, and why early regulatory collaboration is ...
Raja Shankar, VP of machine learning at IQVIA, discusses which AI capabilities sponsors are most likely to adopt first to ...
Realize how to find the audit trail records you need for compliance monitoring Head of Clinical Operations Head of Clinical ...
In today’s ACT Brief, we highlight how purpose-driven efficiency is reshaping clinical development priorities, where leaders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results